Holderness Investments Co
Source: SEC Form 13F · as of Mar 2026Holderness Investments Co holds 17 biotech & pharma companies tracked by BioSniper, totaling $31.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$31.8M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 23,153 | $5.0M |
| MRKMerck & Co., Inc. | 33,090 | $4.0M |
| JNJJOHNSON & JOHNSON | 13,881 | $3.4M |
| AMGNAMGEN INC | 8,038 | $2.8M |
| MCKMcKesson Corporation | 3,061 | $2.6M |
| PFEPFIZER INC | 75,100 | $2.1M |
| BMYBRISTOL MYERS SQUIBB CO | 34,714 | $2.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 6,710 | $1.8M |
| NVSNovartis AG | 10,458 | $1.6M |
| LLYELI LILLY & Co | 1,702 | $1.6M |
| GILDGILEAD SCIENCES, INC. | 10,720 | $1.5M |
| PMPhilip Morris International Inc | 8,861 | $1.5M |
| ABTABBOTT LABORATORIES | 4,376 | $449K |
| NVONovo Nordisk A/S | 11,388 | $419K |
| DGXQuest Diagnostics Incorporated | 2,000 | $392K |
| CAHCardinal Health Inc. | 1,125 | $238K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 489 | $218K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.